Brief: Cipher Pharmaceuticals Reports Q2 Revenue Of $4.7 Mln
Aug 12 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS
* CIPHER PHARMACEUTICALS INC - QTRLY TOTAL REVENUE WAS $4.7
MILLION COMPARED TO $5.6 MILLION
* CIPHER PHARMACEUTICALS INC - QTRLY ADJUSTED EARNINGS PER
SHARE
$0.07
Source text for Eikon: ID:nCNWfrKKsa
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million